Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17th
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc.(Venus Concept or the Company)(NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
- TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc.(Venus Concept or the Company)(NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
- Management will participate in a virtual fireside chat at the conference on Wednesday, February 17th at 10:00 a.m. Eastern Time.
- Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets.
- Venus Concepts product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD.